2-tert-butyl-4-chloro-[1,3]thiazolo[4,5-c]pyridine;4-(3-tert-butyl-7H-cyclopenta[b]pyridin-5-yl)morpholine;1-tert-butyl-2,3-dihydroindolizine;3-tert-butyl-1,5-dimethyl-5,7-dihydro-4H-indazol-6-one;5-tert-butyl-1-(2-fluorophenyl)-3-methylpyrazole;3-(5-tert-butyl-2-fluorophenyl)-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepine;5-tert-butyl-7-methyl-6,8-dihydro-5H-1,7-naphthyridine;7-tert-butyl-5-methyl-[1,2,4]triazolo[1,5-a][1,3,5]triazine;1-(4-tert-butyl-2-pyridinyl)-3,4,4a,5,6,7,8,8a-octahydro-2H-quinoline;7-tert-butyl-4H-[1,2,4]triazolo[1,5-a]pyrimidin-5-one
C131H182ClF2N25O3S — CID 159933778
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-tert-butyl-4-chloro-[1,3]thiazolo[4,5-c]pyridine;4-(3-tert-butyl-7H-cyclopenta[b]pyridin-5-yl)morpholine;1-tert-butyl-2,3-dihydroindolizine;3-tert-butyl-1,5-dimethyl-5,7-dihydro-4H-indazol-6-one;5-tert-butyl-1-(2-fluorophenyl)-3-methylpyrazole;3-(5-tert-butyl-2-fluorophenyl)-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepine;5-tert-butyl-7-methyl-6,8-dihydro-5H-1,7-naphthyridine;7-tert-butyl-5-methyl-[1,2,4]triazolo[1,5-a][1,3,5]triazine;1-(4-tert-butyl-2-pyridinyl)-3,4,4a,5,6,7,8,8a-octahydro-2H-quinoline;7-tert-butyl-4H-[1,2,4]triazolo[1,5-a]pyrimidin-5-one
2-tert-butyl-4-chloro-[1,3]thiazolo[4,5-c]pyridine;4-(3-tert-butyl-7H-cyclopenta[b]pyridin-5-yl)morpholine;1-tert-butyl-2,3-dihydroindolizine;3-tert-butyl-1,5-dimethyl-5,7-dihydro-4H-indazol-6-one;5-tert-butyl-1-(2-fluorophenyl)-3-methylpyrazole;3-(5-tert-butyl-2-fluorophenyl)-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepine;5-tert-butyl-7-methyl-6,8-dihydro-5H-1,7-naphthyridine;7-tert-butyl-5-methyl-[1,2,4]triazolo[1,5-a][1,3,5]triazine;1-(4-tert-butyl-2-pyridinyl)-3,4,4a,5,6,7,8,8a-octahydro-2H-quinoline;7-tert-butyl-4H-[1,2,4]triazolo[1,5-a]pyrimidin-5-one (PubChem CID 159933778) has the molecular formula C131H182ClF2N25O3S and a molecular weight of 2260.58 g/mol. Its IUPAC name is 2-tert-butyl-4-chloro-[1,3]thiazolo[4,5-c]pyridine;4-(3-tert-butyl-7H-cyclopenta[b]pyridin-5-yl)morpholine;1-tert-butyl-2,3-dihydroindolizine;3-tert-butyl-1,5-dimethyl-5,7-dihydro-4H-indazol-6-one;5-tert-butyl-1-(2-fluorophenyl)-3-methylpyrazole;3-(5-tert-butyl-2-fluorophenyl)-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepine;5-tert-butyl-7-methyl-6,8-dihydro-5H-1,7-naphthyridine;7-tert-butyl-5-methyl-[1,2,4]triazolo[1,5-a][1,3,5]triazine;1-(4-tert-butyl-2-pyridinyl)-3,4,4a,5,6,7,8,8a-octahydro-2H-quinoline;7-tert-butyl-4H-[1,2,4]triazolo[1,5-a]pyrimidin-5-one.
Molecular Properties
| Compound Name | 2-tert-butyl-4-chloro-[1,3]thiazolo[4,5-c]pyridine;4-(3-tert-butyl-7H-cyclopenta[b]pyridin-5-yl)morpholine;1-tert-butyl-2,3-dihydroindolizine;3-tert-butyl-1,5-dimethyl-5,7-dihydro-4H-indazol-6-one;5-tert-butyl-1-(2-fluorophenyl)-3-methylpyrazole;3-(5-tert-butyl-2-fluorophenyl)-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepine;5-tert-butyl-7-methyl-6,8-dihydro-5H-1,7-naphthyridine;7-tert-butyl-5-methyl-[1,2,4]triazolo[1,5-a][1,3,5]triazine;1-(4-tert-butyl-2-pyridinyl)-3,4,4a,5,6,7,8,8a-octahydro-2H-quinoline;7-tert-butyl-4H-[1,2,4]triazolo[1,5-a]pyrimidin-5-one |
|---|---|
| PubChem CID | 159933778 |
| Molecular Formula | C131H182ClF2N25O3S |
| Molecular Weight | 2260.58 g/mol |
| Exact Mass | 2258.42 |
| IUPAC Name | 2-tert-butyl-4-chloro-[1,3]thiazolo[4,5-c]pyridine;4-(3-tert-butyl-7H-cyclopenta[b]pyridin-5-yl)morpholine;1-tert-butyl-2,3-dihydroindolizine;3-tert-butyl-1,5-dimethyl-5,7-dihydro-4H-indazol-6-one;5-tert-butyl-1-(2-fluorophenyl)-3-methylpyrazole;3-(5-tert-butyl-2-fluorophenyl)-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepine;5-tert-butyl-7-methyl-6,8-dihydro-5H-1,7-naphthyridine;7-tert-butyl-5-methyl-[1,2,4]triazolo[1,5-a][1,3,5]triazine;1-(4-tert-butyl-2-pyridinyl)-3,4,4a,5,6,7,8,8a-octahydro-2H-quinoline;7-tert-butyl-4H-[1,2,4]triazolo[1,5-a]pyrimidin-5-one |
| SMILES | CC(C)(C)C1=C2C=CC=CN2CC1.CC(C)(C)c1cc(=O)[nH]c2ncnn12.CC(C)(C)c1ccc(F)c(-c2nnc3n2CCCCC3)c1.CC(C)(C)c1ccnc(N2CCCC3CCCCC32)c1.CC(C)(C)c1cnc2c(c1)C(N1CCOCC1)=CC2.CC(C)(C)c1nc2c(Cl)nccc2s1.CC1Cc2c(C(C)(C)C)nn(C)c2CC1=O.CN1Cc2ncccc2C(C(C)(C)C)C1.Cc1cc(C(C)(C)C)n(-c2ccccc2F)n1.Cc1nc(C(C)(C)C)n2ncnc2n1 |
| InChI | InChI=1S/C18H28N2.C17H22FN3.C16H22N2O.C14H17FN2.C13H20N2O.C13H20N2.C12H17N.C10H11ClN2S.C9H13N5.C9H12N4O/c1-18(2,3)15-10-11-19-17(13-15)20-12-6-8-14-7-4-5-9-16(14)20;1-17(2,3)12-8-9-14(18)13(11-12)16-20-19-15-7-5-4-6-10-21(15)16;1-16(2,3)12-10-13-14(17-11-12)4-5-15(13)18-6-8-19-9-7-18;1-10-9-13(14(2,3)4)17(16-10)12-8-6-5-7-11(12)15;1-8-6-9-10(7-11(8)16)15(5)14-12(9)13(2,3)4;1-13(2,3)11-8-15(4)9-12-10(11)6-5-7-14-12;1-12(2,3)10-7-9-13-8-5-4-6-11(10)13;1-10(2,3)9-13-7-6(14-9)4-5-12-8(7)11;1-6-12-7(9(2,3)4)14-8(13-6)10-5-11-14;1-9(2,3)6-4-7(14)12-8-10-5-11-13(6)8/h10-11,13-14,16H,4-9,12H2,1-3H3;8-9,11H,4-7,10H2,1-3H3;5,10-11H,4,6-9H2,1-3H3;5-9H,1-4H3;8H,6-7H2,1-5H3;5-7,11H,8-9H2,1-4H3;4-6,8H,7,9H2,1-3H3;4-5H,1-3H3;5H,1-4H3;4-5H,1-3H3,(H,10,11,12,14) |
| InChIKey | NZZAXRBEYGRQBR-UHFFFAOYSA-N |
| XLogP | 28.11 |
| TPSA | 289.08 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 28 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 163 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2260.58 |
| LogP ≤ 5 | 28.11 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 28 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': '2-halo_pyridine', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159933778 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.